Table 2. Demographic characteristics of the patients in Cohort2.

	Age	Gender	TNM Stage	Primary tumor site	Perineural invasion	Lymphatic invasion	Venous invasion	regime	RFS (months)
Case1	56	Male	II	Ascending colon	No	No	No	Capecitabine (single)	37.5
Case2	61	Male	II	Ascending colon	No	No	No	Capecitabine (single)	26.8
Case3	57	Male	II	Ascending colon	No	No	No	Capecitabine (single)	41.3
Case4	58	Female	II	Sigmoid colon	No	No	No	Capecitabine (single)	28.7
Case5	55	Male	II	Ascending colon	No	No	No	Capecitabine (single)	45.1
Case6	55	Male	II	Rectum	No	No	No	Capecitabine (single)	33.8
Case7	52	Female	II	Rectum	No	No	No	Capecitabine (single)	32.7
Case8	69	Male	II	Rectum	No	No	No	Capecitabine (single)	35.6